NMTC — Neuroone Medical Technologies Corp
NASDAQ · Healthcare · Medical Devices
$1.59
-$0.02 (-1.24%)
Neuroone Medical Technologies Corp (NMTC) is a medical devices company listed on NASDAQ. It is led by David A. Rosa M.D., based in 7599 Anagram Drive, Eden Prairie, MN, United States, 55344, with about 17 employees. NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, radio frequency and brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company also focuses on applications of its technology associated with artificial intelligence. It has partnership with RBC Medical Innovations to develop a radio frequency ablation generator. NeuroOne Medical Technologies Corporation is based in Eden Prairie, Minnesota.
Latest reported NMTC revenue for 2025-06-30 was $1.7M. Net income was -$1.5M. Revenue was up 22.3% from 2025-03-31 to 2025-06-30. NMTC currently screens at market cap $35.5M.
Use this NMTC page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the NMTC quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the NMTC SEC filings page. Lician reads the product cache first so this HTML stays unique to Neuroone Medical Technologies Corp even when a live quote feed is slow.
About Neuroone Medical Technologies Corp
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, radio frequency and brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company also focuses on applications of its technology associated with artificial intelligence. It has partnership with RBC Medical Innovations to develop a radio frequency ablation generator. NeuroOne Medical Technologies Corporation is based in Eden Prairie, Minnesota.
NMTC Key Statistics
Market Cap
$35.47M
Volume
23,918
Previous Close
$2.14
Day Range
$2.10 – $2.20
EPS
-$0.46
Revenue
$3.45M
Net Income
-$12.32M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+76.9%
Profit Margin
-356.7%
Employees
17
NMTC Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $3.45M | $1.95M | $171.17K | $178.15K |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$12.32M | -$11.86M | -$10.00M | -$9.95M |
| EPS (Diluted) | -$0.46 | -$0.65 | -$0.63 | -$0.93 |
Total Assets
$5.37M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$1.46M
Operating Cash Flow
-$11.01M
Free Cash Flow
$0.00
Neuroone Medical Technologies Corp Company Information
- President, CEO & Director
- David A. Rosa M.D.
- Headquarters
- 7599 Anagram Drive, Eden Prairie, MN, United States, 55344
- Website
- nmtc1.com
- Phone
- 952 426 1383
- IPO / Founded
- 2017-09-18
- Sector
- Healthcare
- Industry
- Medical Devices